{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:41:19Z","timestamp":1773819679562,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["25fk0210166"],"award-info":[{"award-number":["25fk0210166"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07991"],"award-info":[{"award-number":["22K07991"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11175"],"award-info":[{"award-number":["24K11175"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["2024047543"],"award-info":[{"award-number":["2024047543"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00216-026-06338-z","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:27:09Z","timestamp":1769102829000},"page":"2125-2133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a hypersensitive digital ELISA system for hepatitis B core antigen"],"prefix":"10.1007","volume":"418","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0888-204X","authenticated-orcid":false,"given":"Yuki","family":"Nakaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4678-6147","authenticated-orcid":false,"given":"Takema","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8240-2446","authenticated-orcid":false,"given":"Daichi","family":"Onomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0827-0964","authenticated-orcid":false,"given":"Hiroaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3419-6297","authenticated-orcid":false,"given":"Kazumoto","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4930-4852","authenticated-orcid":false,"given":"Megumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"6338_CR1","unstructured":"World Health Organization. World health statistics 2024: monitoring health for the SDGs. Sustainable Development Goals. 2024."},{"issue":"3","key":"6338_CR2","doi-asserted-by":"publisher","first-page":"100112","DOI":"10.1016\/j.jhepr.2020.100112","volume":"2","author":"CL Lai","year":"2020","unstructured":"Lai CL, Wong DK, Wong GT, Seto WK, Fung J, Yuen MF. Rebound of HBV DNA after cessation of nucleos\/tide analogues in chronic hepatitis B patients with undetectable covalently closed circular DNA. JHEP Rep. 2020;2(3):100112.","journal-title":"JHEP Rep"},{"key":"6338_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/PPA.S127139","volume":"11","author":"X Xue","year":"2017","unstructured":"Xue X, Cai S, Ou H, Zheng C, Wu X. Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment. Patient Prefer Adherence. 2017;11:85\u201393.","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"6338_CR4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jhep.2022.12.018","volume":"78","author":"F van Bommel","year":"2023","unstructured":"van Bommel F, Stein K, Heyne R, Petersen J, Buggisch P, Berg C, et al. A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B. J Hepatol. 2023;78(5):926\u201336.","journal-title":"J Hepatol"},{"issue":"1","key":"6338_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12876-023-02852-x","volume":"23","author":"Y Xie","year":"2023","unstructured":"Xie Y, Li M, Ou X, Zheng S, Gao Y, Xu X, et al. Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation. BMC Gastroenterol. 2023;23(1):224.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"6338_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1\u201398.","journal-title":"Hepatol Int"},{"issue":"9","key":"6338_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/v11090783","volume":"11","author":"V Svicher","year":"2019","unstructured":"Svicher V, Salpini R, Malagnino V, Piermatteo L, Alkhatib M, Cerva C, et al. New markers in monitoring the reactivation of hepatitis B virus infection in immunocompromised hosts. Viruses. 2019;11(9):783.","journal-title":"Viruses"},{"issue":"6","key":"6338_CR8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","volume":"76","author":"GLH Wong","year":"2022","unstructured":"Wong GLH, Gane E, Lok ASF. How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development? J Hepatol. 2022;76(6):1249\u201362.","journal-title":"J Hepatol"},{"issue":"12","key":"6338_CR9","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/phar.2340","volume":"39","author":"DJ Smalls","year":"2019","unstructured":"Smalls DJ, Kiger RE, Norris LB, Bennett CL, Love BL. Hepatitis B virus reactivation: risk factors and current management strategies. Pharmacotherapy. 2019;39(12):1190\u2013203.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"6338_CR10","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/v14020434","volume":"14","author":"RN Chien","year":"2022","unstructured":"Chien RN, Liaw YF. Current trend in antiviral therapy for chronic hepatitis B. Viruses. 2022;14(2):434.","journal-title":"Viruses"},{"issue":"3","key":"6338_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/hep.21282","volume":"44","author":"K Wursthorn","year":"2006","unstructured":"Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, et al. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology. 2006;44(3):675\u201384.","journal-title":"Hepatology"},{"issue":"6","key":"6338_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","volume":"81","author":"F Zoulim","year":"2024","unstructured":"Zoulim F, Chen PJ, Dandri M, Kennedy PT, Seeger C. Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome. J Hepatol. 2024;81(6):1087\u201399.","journal-title":"J Hepatol"},{"issue":"3","key":"6338_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3350\/cmh.2020.0032","volume":"26","author":"T Inoue","year":"2020","unstructured":"Inoue T, Tanaka Y. Novel biomarkers for the management of chronic hepatitis B. Clin Mol Hepatol. 2020;26(3):261\u201379.","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"6338_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jhep.2021.02.017","volume":"75","author":"T Inoue","year":"2021","unstructured":"Inoue T, Kusumoto S, Iio E, Ogawa S, Suzuki T, Yagi S, et al. Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation. J Hepatol. 2021;75(2):302\u201310.","journal-title":"J Hepatol"},{"issue":"1","key":"6338_CR15","doi-asserted-by":"publisher","first-page":"98658","DOI":"10.4254\/wjh.v17.i1.98658","volume":"17","author":"Y Qiu","year":"2025","unstructured":"Qiu Y, Tang Q, Liu XQ, Xue YL, Zeng Y, Hu P. Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure. World J Hepatol. 2025;17(1):98658.","journal-title":"World J Hepatol"},{"issue":"1","key":"6338_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jmv.21339","volume":"81","author":"F Suzuki","year":"2009","unstructured":"Suzuki F, Miyakoshi H, Kobayashi M, Kumada H. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients. J Med Virol. 2009;81(1):27\u201333.","journal-title":"J Med Virol"},{"issue":"3","key":"6338_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/liv.14330","volume":"40","author":"GL Wong","year":"2020","unstructured":"Wong GL, Chan HL, Yuen BW, Tse YK, Luk HW, Yip TC, et al. The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B. Liver Int. 2020;40(3):549\u201357.","journal-title":"Liver Int"},{"issue":"4","key":"6338_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jhep.2022.12.017","volume":"78","author":"C Adraneda","year":"2023","unstructured":"Adraneda C, Tan YC, Yeo EJ, Kew GS, Khakpoor A, Lim SG. A critique and systematic review of the clinical utility of hepatitis B core-related antigen. J Hepatol. 2023;78(4):731\u201341.","journal-title":"J Hepatol"},{"issue":"1","key":"6338_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3748\/wjg.v13.i1.48","volume":"13","author":"J Beck","year":"2007","unstructured":"Beck J, Nassal M. Hepatitis B virus replication. World J Gastroenterol. 2007;13(1):48\u201364.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"6338_CR20","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1128\/JCM.41.5.1901-1906.2003","volume":"41","author":"T Kimura","year":"2003","unstructured":"Kimura T, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, et al. New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA. J Clin Microbiol. 2003;41(5):1901\u20136.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"6338_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","volume":"72","author":"EE Conners","year":"2023","unstructured":"Conners EE, Panagiotakopoulos L, Hofmeister MG, Spradling PR, Hagan LM, Harris AM, et al. Screening and testing for hepatitis B virus infection: CDC recommendations - United States, 2023. MMWR Recomm Rep. 2023;72(1):1\u201325.","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"6338_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41575-022-00649-z","volume":"19","author":"A Kramvis","year":"2022","unstructured":"Kramvis A, Chang KM, Dandri M, Farci P, Glebe D, Hu J, et al. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat Rev Gastroenterol Hepatol. 2022;19(11):727\u201345.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1-2","key":"6338_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jim.2012.02.011","volume":"378","author":"L Chang","year":"2012","unstructured":"Chang L, Rissin DM, Fournier DR, Piech T, Patel PP, Wilson DH, et al. Single molecule enzyme-linked immunosorbent assays: theoretical considerations. J Immunol Methods. 2012;378(1\u20132):102\u201315.","journal-title":"J Immunol Methods"},{"issue":"1","key":"6338_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1021\/acs.analchem.6b04290","volume":"89","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Noji H. Digital bioassays: theory, applications, and perspectives. Anal Chem. 2017;89(1):92\u2013101.","journal-title":"Anal Chem"},{"issue":"10","key":"6338_CR25","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s00216-023-04600-2","volume":"415","author":"T Hasegawa","year":"2023","unstructured":"Hasegawa T, Shibayama S, Osumi Y, Sentsui H, Kato M. Quantitative performance of digital ELISA for the highly sensitive quantification of viral proteins and influenza virus. Anal Bioanal Chem. 2023;415(10):1897\u2013904.","journal-title":"Anal Bioanal Chem"},{"issue":"41","key":"6338_CR26","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.1039\/D4AY01012D","volume":"16","author":"T Hasegawa","year":"2024","unstructured":"Hasegawa T, Adachi Y, Saikusa K, Kato M. Establishment and characterization of noro-VLP measurement by digital ELISA. Anal Methods. 2024;16(41):7089\u201394.","journal-title":"Anal Methods"},{"issue":"1","key":"6338_CR27","doi-asserted-by":"publisher","first-page":"10958","DOI":"10.1038\/s41598-023-37223-9","volume":"13","author":"YV Kuzmichev","year":"2023","unstructured":"Kuzmichev YV, Lackman-Smith C, Bakkour S, Wiegand A, Bale MJ, Musick A, et al. Application of ultrasensitive digital ELISA for p24 enables improved evaluation of HIV-1 reservoir diversity and growth kinetics in viral outgrowth assays. Sci Rep. 2023;13(1):10958.","journal-title":"Sci Rep"},{"key":"6338_CR28","doi-asserted-by":"publisher","first-page":"1331981","DOI":"10.3389\/fimmu.2023.1331981","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wei P. Shifting the paradigm in RNA virus detection: integrating nucleic acid testing and immunoassays through single-molecule digital ELISA. Front Immunol. 2023;14:1331981.","journal-title":"Front Immunol"},{"issue":"6","key":"6338_CR29","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.4049\/jimmunol.130.6.2903","volume":"130","author":"K Takahashi","year":"1983","unstructured":"Takahashi K, Machida A, Funatsu G, Nomura M, Usuda S, Aoyagi S, et al. Immunochemical structure of hepatitis B e antigen in the serum. J Immunol. 1983;130(6):2903\u20137.","journal-title":"J Immunol"},{"issue":"2","key":"6338_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0166-0934(97)00125-0","volume":"68","author":"S Usuda","year":"1997","unstructured":"Usuda S, Okamoto H, Ohnuma H, Tanaka T, Machida A, Miyakawa Y, et al. A monoclonal antibody against a hepatitis B e antigen epitope borne by six amino acids encoded by the precore region. J Virol Methods. 1997;68(2):207\u201315.","journal-title":"J Virol Methods"},{"issue":"1","key":"6338_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/infdis\/jiae353","volume":"231","author":"Y Nakaya","year":"2025","unstructured":"Nakaya Y, Onomura D, Hoshi Y, Yamagata T, Morita H, Okamoto H, et al. Establishment of a hepatitis B virus reporter system harboring an HiBiT-tag in the PreS2 region. J Infect Dis. 2025;231(1):204\u201313.","journal-title":"J Infect Dis"},{"issue":"1","key":"6338_CR32","doi-asserted-by":"publisher","first-page":"13584","DOI":"10.1038\/s41598-023-40688-3","volume":"13","author":"Y Nakaya","year":"2023","unstructured":"Nakaya Y, Nishizawa T, Nishitsuji H, Morita H, Yamagata T, Onomura D, et al. TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein. Sci Rep. 2023;13(1):13584.","journal-title":"Sci Rep"},{"issue":"3","key":"6338_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/v9030056","volume":"9","author":"J Hu","year":"2017","unstructured":"Hu J, Liu K. Complete and incomplete hepatitis B virus particles: formation, function, and application. Viruses. 2017;9(3):56.","journal-title":"Viruses"},{"issue":"4","key":"6338_CR34","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4254\/wjh.v14.i4.708","volume":"14","author":"R Kumar","year":"2022","unstructured":"Kumar R. Review on hepatitis B virus precore\/core promoter mutations and their correlation with genotypes and liver disease severity. World J Hepatol. 2022;14(4):708\u201318.","journal-title":"World J Hepatol"},{"issue":"3","key":"6338_CR35","doi-asserted-by":"publisher","first-page":"e01695","DOI":"10.1128\/JVI.01695-20","volume":"95","author":"X Hong","year":"2021","unstructured":"Hong X, Luckenbaugh L, Mendenhall M, Walsh R, Cabuang L, Soppe S, et al. Characterization of hepatitis B precore\/core-related antigens. J Virol. 2021;95(3):e01695-20.","journal-title":"J Virol"},{"issue":"1","key":"6338_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jhep.2022.01.021","volume":"77","author":"D Huang","year":"2022","unstructured":"Huang D, Wu D, Wang P, Wang Y, Yuan W, Hu D, et al. End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB. J Hepatol. 2022;77(1):42\u201354.","journal-title":"J Hepatol"},{"issue":"4","key":"6338_CR37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/gutjnl-2023-330644","volume":"73","author":"B Testoni","year":"2024","unstructured":"Testoni B, Scholtes C, Plissonnier ML, Paturel A, Berby F, Facchetti F, et al. Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B. Gut. 2024;73(4):659\u201367.","journal-title":"Gut"},{"key":"6338_CR38","doi-asserted-by":"publisher","first-page":"105150","DOI":"10.1016\/j.jcv.2022.105150","volume":"150-151","author":"C Scholtes","year":"2022","unstructured":"Scholtes C, Hamilton AT, Plissonnier ML, Charre C, Scott B, Wang L, et al. Performance of the cobas(R) HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients. J Clin Virol. 2022;150\u2013151:105150.","journal-title":"J Clin Virol"},{"key":"6338_CR39","doi-asserted-by":"publisher","first-page":"115536","DOI":"10.1016\/j.bios.2023.115536","volume":"237","author":"AD Stephens","year":"2023","unstructured":"Stephens AD, Song Y, McClellan BL, Su SH, Xu S, Chen K, et al. Miniaturized microarray-format digital ELISA enabled by lithographic protein patterning. Biosens Bioelectron. 2023;237:115536.","journal-title":"Biosens Bioelectron"},{"key":"6338_CR40","doi-asserted-by":"publisher","first-page":"339926","DOI":"10.1016\/j.aca.2022.339926","volume":"1213","author":"H Ashiba","year":"2022","unstructured":"Ashiba H, Yasuura M, Fukuda T, Hatano K, Fujimaki M. Quick and ultra-sensitive digital assay of influenza virus using sub-picoliter microwells. Anal Chim Acta. 2022;1213:339926.","journal-title":"Anal Chim Acta"},{"issue":"3","key":"6338_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s00535-016-1244-7","volume":"52","author":"A Matsumoto","year":"2017","unstructured":"Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, et al. Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody. J Gastroenterol. 2017;52(3):376\u201384.","journal-title":"J Gastroenterol"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-026-06338-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06338-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:36:20Z","timestamp":1773815780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-026-06338-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["6338"],"URL":"https:\/\/doi.org\/10.1007\/s00216-026-06338-z","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}